Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches.

Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches. Abstract Text:

The mitochondrial trifunctional protein (MTP) is a heterotrimeric protein that consists of four alpha-subunits and four beta-subunits and catalyzes three of the four chain-shortening reactions in the mitochondrial beta-oxidation of long-chain fatty acids. Families with recessively inherited MTP defects display a spectrum of maternal and fetal phenotypes. Current management of patients with MTP defects include long-term dietary therapy of fasting avoidance, low-fat/high-carbohydrate diet with restriction of long-chain fatty acid intake and substitution with medium-chain fatty acids. These dietary approaches appear promising in the short-term, but the long-term outcome of patients treated with dietary intervention is largely unknown. Potential therapeutic approaches targeted at correcting the metabolic defect will be discussed. We will discuss the potential use of protein transduction domains that cross the mitochondrial membranes for the treatment of mitochondrial disorders. In addition, we discuss the phenotypes of MTP in a heterozygous state and potential ways to intervene to increase hepatic fatty acid oxidative capacity.

Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE: 2008 Oct-Nov

Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Advanced drug delivery reviews

VOLUME: 60

Page Numbers: 1488-96

Journal Abbreviation: Adv. Drug Deliv. Rev.

ISSN: 0169-409X

DAY: 4

MONTH: 07

YEAR: 2008

Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8710523

Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches.

AFFILIATION: Division of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri 65212, USA.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Adv Drug Deliv Rev

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches Related Publications

• Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats.
• Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
• Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats.
• How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review.
• Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches.
• Non-alcoholic fatty liver disease and the metabolic syndrome: An update.
• Nonalcoholic fatty liver disease and mitochondrial dysfunction.
• Post-mortem analysis for two prevalent beta-oxidation mutations in sudden infant death.
• Role of the JNK signal transduction pathway in inflammatory bowel disease.